MX19722A - Procedimiento para la preparacion de fosfato de (3-(c16-c18)-alcanossulfinil- y sulfonil-2metoximetilpropil)-(2-trimetilamonioetil). - Google Patents

Procedimiento para la preparacion de fosfato de (3-(c16-c18)-alcanossulfinil- y sulfonil-2metoximetilpropil)-(2-trimetilamonioetil).

Info

Publication number
MX19722A
MX19722A MX1972290A MX1972290A MX19722A MX 19722 A MX19722 A MX 19722A MX 1972290 A MX1972290 A MX 1972290A MX 1972290 A MX1972290 A MX 1972290A MX 19722 A MX19722 A MX 19722A
Authority
MX
Mexico
Prior art keywords
preparation
trimetilamonioetil
alcanossulfinil
sulfonil
phosphate
Prior art date
Application number
MX1972290A
Other languages
English (en)
Inventor
Elmar Bosies
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of MX19722A publication Critical patent/MX19722A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
MX1972290A 1989-03-04 1990-03-01 Procedimiento para la preparacion de fosfato de (3-(c16-c18)-alcanossulfinil- y sulfonil-2metoximetilpropil)-(2-trimetilamonioetil). MX19722A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3906952A DE3906952A1 (de) 1989-03-04 1989-03-04 (3-(c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)6(pfeil abwaerts)-c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)8(pfeil abwaerts))alkansulfinyl- und sulfonyl-2-methoxymethyl-propyl)-(2-trimethylammonio-ethyl) phosphate, verfahren zu deren herstellung diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
MX19722A true MX19722A (es) 1993-11-01

Family

ID=6375519

Family Applications (1)

Application Number Title Priority Date Filing Date
MX1972290A MX19722A (es) 1989-03-04 1990-03-01 Procedimiento para la preparacion de fosfato de (3-(c16-c18)-alcanossulfinil- y sulfonil-2metoximetilpropil)-(2-trimetilamonioetil).

Country Status (19)

Country Link
US (1) US5543402A (es)
EP (1) EP0395849B1 (es)
JP (1) JPH0341027A (es)
KR (1) KR900014412A (es)
AT (1) ATE121409T1 (es)
AU (1) AU633304B2 (es)
CA (1) CA2011209A1 (es)
DD (1) DD292259A5 (es)
DE (2) DE3906952A1 (es)
FI (1) FI93122C (es)
HU (1) HU204057B (es)
IE (1) IE900743L (es)
IL (1) IL93598A (es)
MX (1) MX19722A (es)
NO (1) NO901008L (es)
NZ (1) NZ232692A (es)
PT (1) PT93324B (es)
RU (1) RU2035466C1 (es)
ZA (1) ZA901601B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3929217A1 (de) * 1989-09-02 1991-03-07 Boehringer Mannheim Gmbh Verwendung von phospholipid-derivaten als antivirale arzneimittel und neue phospholipide
GB8928580D0 (en) * 1989-12-19 1990-02-21 Scras 3-(n-methyl-n-alkylamino)-methoxymethyl-propanol phosphocholine derivatives
US6172050B1 (en) 1992-07-11 2001-01-09 Asta Medica Aktiengesellschaft Phospholipid derivatives
DE4222910A1 (de) * 1992-07-11 1994-01-13 Asta Medica Ag Neue Phospholipidderivate
WO1994002153A1 (en) * 1992-07-22 1994-02-03 Boehringer Mannheim Gmbh Use of sulphur containing phospholipids for treating leishmaniasis
CA2774959C (en) * 2000-08-04 2016-05-31 Dmi Biosciences, Inc. Method of using diketopiperazines and composition containing them
KR100469556B1 (ko) * 2001-11-17 2005-02-02 주식회사 건축사사무소다인그룹 도어 잠금장치
CA2468099A1 (en) * 2001-11-21 2003-05-30 Ganymed 256 Vermogensverwaltungs Gmbh Phospholipid derivatives of nucleosides as antitumoral medicaments
US7575929B2 (en) * 2002-10-02 2009-08-18 Dmi Life Sciences, Inc. Diagnosis of multiple sclerosis with diketopiperazines
CN103191409A (zh) 2003-05-15 2013-07-10 Dmi生物科学公司 T-细胞介导的疾病的治疗
US8217047B2 (en) * 2008-05-27 2012-07-10 Dmi Acquisition Corp. Therapeutic methods and compounds
CA2810844C (en) 2010-09-07 2017-03-21 Dmi Acquisition Corp. Diketopiperazine compositions for the treatment of metabolic syndrome and related conditions
EP2765968A4 (en) 2011-10-10 2015-01-21 Ampio Pharmaceuticals Inc IMPLANTABLE MEDICINE PRODUCTS WITH INCREASED IMMUNO TOLERANCE AND PROCESSING AND IMPLANTATION METHODS
CA2846598C (en) 2011-10-10 2019-12-10 Ampio Pharmaceuticals, Inc. Treatment of degenerative joint disease
HK1198812A1 (en) 2011-10-28 2015-06-12 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
EA201500943A1 (ru) 2013-03-15 2016-08-31 Ампио Фармасьютикалс, Инк. Составы для мобилизации, хоуминга, размножения и дифференцировки стволовых клеток и способы применения составов
CA2958080A1 (en) 2014-08-18 2016-02-25 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
US11389512B2 (en) 2015-06-22 2022-07-19 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2009341C3 (de) * 1970-02-27 1979-06-21 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen 3-Octadecyloxy-propanol-(l)-phosphorsäure-monocholinester und Verfahren zu dessen Herstellung
DE2619686C2 (de) * 1976-05-04 1986-08-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verwendung eines Lysolecithins zur Tumorbehandlung
DE2619715A1 (de) * 1976-05-04 1977-11-24 Max Planck Gesellschaft Tumor-antigen und verfahren zu dessen herstellung
GB2046092B (en) * 1979-03-05 1983-11-02 Toyama Chemical Co Ltd Pharmaceutical composition containing a lysophospholid and a phospholipid
DE3164332D1 (en) * 1980-10-21 1984-07-26 Boehringer Mannheim Gmbh Phospholipids that contain sulphur, process for their preparation and medicines containing these compounds
DE3127503A1 (de) * 1981-07-11 1983-02-17 Boehringer Mannheim Gmbh, 6800 Mannheim Neue phospholipide, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE3304870A1 (de) * 1983-02-12 1984-08-16 Boehringer Mannheim Gmbh, 6800 Mannheim Neue phospholipide, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
HU204057B (en) 1991-11-28
RU2035466C1 (ru) 1995-05-20
HU901280D0 (en) 1990-05-28
IE900743L (en) 1990-09-04
PT93324B (pt) 1996-02-29
FI93122C (fi) 1995-02-27
NZ232692A (en) 1992-06-25
FI901096A0 (fi) 1990-03-02
EP0395849B1 (de) 1995-04-19
AU633304B2 (en) 1993-01-28
KR900014412A (ko) 1990-10-23
AU5059690A (en) 1990-09-06
CA2011209A1 (en) 1990-09-04
DE59008915D1 (de) 1995-05-24
DE3906952A1 (de) 1990-09-06
NO901008D0 (no) 1990-03-02
HUT53111A (en) 1990-09-28
EP0395849A1 (de) 1990-11-07
ATE121409T1 (de) 1995-05-15
US5543402A (en) 1996-08-06
IL93598A (en) 1994-06-24
FI93122B (fi) 1994-11-15
PT93324A (pt) 1990-11-07
JPH0341027A (ja) 1991-02-21
ZA901601B (en) 1990-12-28
DD292259A5 (de) 1991-07-25
IL93598A0 (en) 1990-12-23
NO901008L (no) 1990-09-05

Similar Documents

Publication Publication Date Title
MX19722A (es) Procedimiento para la preparacion de fosfato de (3-(c16-c18)-alcanossulfinil- y sulfonil-2metoximetilpropil)-(2-trimetilamonioetil).
DE3785198D1 (de) Liposomes praeparat und antibiotikum.
MX16158A (es) Un procedimiento para la preparacion de derivados aromaticos y heterociclicos de carboxiamida, utiles como agentes antitumorales
HU896762D0 (en) Process for preparation of pyrimidine-derivatives and for manufacturing of pharmaceutical compositions containing these compounds
NO880182D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater.
MX10059A (es) Procedimiento para la preparacion de antagonistas de leucotrienos novedosos y producto obtenido
MX13270A (es) Procedimiento para la preparacion de derivados de 4-aminopiridina
NO171412C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater
AR228101A1 (es) Procedimiento para producir compuestos de pirazolo(3,4-b)(1,5)benzodiazepina
MA21854A1 (fr) Procede de preparation de phosphonomethyl thioethoxypurines .
PT87946A (pt) Processo para a preparacao de derivados 4-amino susbtituido-1,2-dihidroxinaftaleno
NO171211C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner
ES499691A0 (es) Procedimiento para la preparacion de derivados de 5,11-dihi-dro-6h-pirido(2,3-b)(1,4)-benzodiazepin-6-ona
ES2061481T3 (es) Derivados de 3,4-dihidrobenzoazina opticamente activos y procedimiento para la preparacion de los mismos.
ES2067621T3 (es) Procedimiento para la preparacion de compuestos molusquicidas de 2,4,5-tribromopirrol-3-carbonitrilo.
NO951606L (no) Nye pseudopeptidforbindelser for neurokininer, fremgangsmåte ved deres fremstilling og farmasöytiske forbindelser inneholdende dem
NO167511C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte tieno(3,4-d)imidazolderivater.
ES541910A0 (es) Procedimiento para la fabricacion de derivados de 4,7-dihi- dropirazolo (3,4-b)piridina
ES2085939T3 (es) Procedimiento para la preparacion de compuestos insecticidas, nematocidas y acaricidas de 4-sustituido-5-(trifluorometil)pirrol-3-carbonitrilo.
MX12051A (es) Procedimiento para preparar nuevos derivados de la1-bencenosulfonil-2-oxo-5-alquiltio-pirrolidina.
ES524353A0 (es) Procedimiento para la preparacion de n-metil-n-bis-(3,4-dimetoxi-fenil-etil)-amina
ES2052812T3 (es) Un procedimiento para la preparacion de derivados de pirrolizina.
ES518427A0 (es) Procedimiento para la preparacion de derivados de 10-amino-tieno (3,2-b)(1,5) benzoxazepinas.
NO890502D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive etanolamin-derivater.
NO891678D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive etanolamin-derivater.